Zepbound

Patients scramble as cheaper obesity drug alternatives disappear

2:02pm March 19, 2025

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop Wednesday. That has left many patients wondering what to do next.

Queue Listen Now

Vial and syringe with liquid drop on top

Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash

5:15am March 05, 2025

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their insurance. Novo Nordisk is now discounting Wegovy for cash customers too.

Queue Listen Now

Collage style hand holding semaglutide Injection Pen cost or money concept with textures and vibrant colors

Thinking of buying obesity drugs online? Read this first

12:15pm February 17, 2025

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.

Drugmakers and pharmacists battle over who gets to make obesity drugs

6:00am November 20, 2024

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.

Ozempic and Wegovy, injectable prescription obesity medicines.

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions

11:57am September 06, 2024

The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.

Queue Listen Now

Health & Safety

Torrid market for copycat weight loss drugs could be short-lived

10:20pm July 24, 2024

by Sydney Lupkin

Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.

Queue Listen Now

Drugmaker Eli Lilly & Co. received Food and Drug Administration approval for an obesity drug called Zepbound that will be a rival to Novo Nordisk's Wegovy.

Health & Safety

FDA approves Zepbound, a new obesity drug that will take on Wegovy

4:58pm November 08, 2023

by Yuki Noguchi

Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.